|
April 2009
Department of Medicine, University of California, San Francisco (MGR07002)
Thursday, 12:00 noon - 1:00 p.m.; Room HSW-300
April 2
|
Update on Genomic Medicine
Robert Nussbaum, MD
Professor of Medicine in Residence
Holly Smith Distinguished Professor of Science and Medicine
Professor of Neurology
University of California, San Francisco
|
|
April 9
|
Quality of Palliative Care
Michael Rabow, MD
Associate Professor of Medicine
University of California, San Francisco
|
|
April 16
|
Asthma and the Microbiome
Homer Boushey, MD
Professor of Medicine
Chief Allergy/Immunology, Division of Pulmonary and Critical Care Medicine
University of California, San Francisco
- To state two possible rationales for treating asthma with a macrolide antibiotic
- To describe the rationale for microbial detection by the 16s-rRNA Phylochip
- To name at least two epidemiologic findings suggesting that exposure to certain microbial populations in infancy may reduce the risk of developing allergies and asthma
|
|
April 23
|
HBV Management for the Internist
Marion Peters, MD
Professor in Residence
University of California, San Francisco
|
|
April 30
|
Antithrombotic Therapy in Ischemic Heart Disease
Elliott Antman, MD
Sampson Memorial Lecture
Professor of Medicine, Cardiovascular Division
Brigham and Women's Hospital
Harvard Medical School, Boston, MA
|
Accreditation
The University of California San Francisco, School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
UCSF designates this educational activity for a maximum of 1.0 hours
in Category I credit toward the AMA PRA Category 1 Credit(s)™.
Physicians should only claim credit commensurate with the extent of
their participation in the activity.
You must sign in to qualify for CME credit.
Course Number MGR08002.
*Faculty Relationship Disclosure
All speakers listed above have declared that neither they, nor any immediate member of their family, have a financial arrangement or other relationship with the manufacturers of any commercial products except * (where noted).
All conflicts of interest have been resolved in accordance with the ACCME's Standards for Commercial Support.
Medical Grand Rounds Commercial Support Disclosure
No commercial support received for April Grand Rounds.
|
